Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.01
UHS's Cash to Debt is ranked lower than
55% of the 245 Companies
in the Global Medical Care industry.

( Industry Median: 0.24 vs. UHS: 0.01 )
UHS' s 10-Year Cash to Debt Range
Min: 0   Max: 0.27
Current: 0.01

0
0.27
Equity to Asset 0.42
UHS's Equity to Asset is ranked higher than
68% of the 242 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. UHS: 0.42 )
UHS' s 10-Year Equity to Asset Range
Min: 0.26   Max: 0.54
Current: 0.42

0.26
0.54
Interest Coverage 6.69
UHS's Interest Coverage is ranked higher than
74% of the 163 Companies
in the Global Medical Care industry.

( Industry Median: 5.75 vs. UHS: 6.69 )
UHS' s 10-Year Interest Coverage Range
Min: 4.47   Max: 11.36
Current: 6.69

4.47
11.36
F-Score: 6
Z-Score: 2.59
M-Score: -2.61
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 13.94
UHS's Operating margin (%) is ranked higher than
85% of the 247 Companies
in the Global Medical Care industry.

( Industry Median: 9.14 vs. UHS: 13.94 )
UHS' s 10-Year Operating margin (%) Range
Min: 7.71   Max: 13.94
Current: 13.94

7.71
13.94
Net-margin (%) 7.01
UHS's Net-margin (%) is ranked higher than
82% of the 247 Companies
in the Global Medical Care industry.

( Industry Median: 4.82 vs. UHS: 7.01 )
UHS' s 10-Year Net-margin (%) Range
Min: 3.51   Max: 7.01
Current: 7.01

3.51
7.01
ROE (%) 15.71
UHS's ROE (%) is ranked higher than
90% of the 239 Companies
in the Global Medical Care industry.

( Industry Median: 8.44 vs. UHS: 15.71 )
UHS' s 10-Year ROE (%) Range
Min: 11.19   Max: 19.99
Current: 15.71

11.19
19.99
ROA (%) 6.14
UHS's ROA (%) is ranked higher than
85% of the 248 Companies
in the Global Medical Care industry.

( Industry Median: 3.59 vs. UHS: 6.14 )
UHS' s 10-Year ROA (%) Range
Min: 3.06   Max: 8.42
Current: 6.14

3.06
8.42
ROC (Joel Greenblatt) (%) 26.06
UHS's ROC (Joel Greenblatt) (%) is ranked higher than
81% of the 246 Companies
in the Global Medical Care industry.

( Industry Median: 15.98 vs. UHS: 26.06 )
UHS' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 13.55   Max: 26.06
Current: 26.06

13.55
26.06
Revenue Growth (%) 8.90
UHS's Revenue Growth (%) is ranked higher than
81% of the 203 Companies
in the Global Medical Care industry.

( Industry Median: 7.00 vs. UHS: 8.90 )
UHS' s 10-Year Revenue Growth (%) Range
Min: 8.6   Max: 18.1
Current: 8.9

8.6
18.1
EBITDA Growth (%) 22.40
UHS's EBITDA Growth (%) is ranked higher than
92% of the 172 Companies
in the Global Medical Care industry.

( Industry Median: 6.70 vs. UHS: 22.40 )
UHS' s 10-Year EBITDA Growth (%) Range
Min: -3.3   Max: 29.5
Current: 22.4

-3.3
29.5
EPS Growth (%) 29.80
UHS's EPS Growth (%) is ranked higher than
88% of the 155 Companies
in the Global Medical Care industry.

( Industry Median: 11.70 vs. UHS: 29.80 )
UHS' s 10-Year EPS Growth (%) Range
Min: -9.8   Max: 29.8
Current: 29.8

-9.8
29.8
» UHS's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

UHS Guru Trades in Q3 2013

Jeremy Grantham 8,229 sh (New)
Ray Dalio 9,800 sh (New)
Jim Simons 37,900 sh (New)
Joel Greenblatt 123,498 sh (+86.9%)
Ron Baron 405,540 sh (+34.51%)
Mariko Gordon 45,939 sh (+11.77%)
Andreas Halvorsen 4,046,906 sh (+7.05%)
Vanguard Health Care Fund 3,873,600 sh (unchged)
Paul Tudor Jones Sold Out
Westport Asset Management 1,048,332 sh (-2.2%)
Steven Cohen 512,731 sh (-5.88%)
Private Capital 619,012 sh (-9.04%)
Chris Davis 167,300 sh (-15.82%)
Manning & Napier Advisors, Inc 241,470 sh (-52.57%)
» More
Q4 2013

UHS Guru Trades in Q4 2013

Paul Tudor Jones 7,354 sh (New)
Ray Dalio 12,500 sh (+27.55%)
Joel Greenblatt 147,392 sh (+19.35%)
Vanguard Health Care Fund 3,873,600 sh (unchged)
Ron Baron 405,540 sh (unchged)
Jim Simons Sold Out
Mariko Gordon 45,667 sh (-0.59%)
Jeremy Grantham 7,889 sh (-4.13%)
Westport Asset Management 947,332 sh (-9.63%)
Chris Davis 147,600 sh (-11.78%)
Manning & Napier Advisors, Inc 203,258 sh (-15.82%)
Andreas Halvorsen 3,009,890 sh (-25.62%)
Private Capital 401,921 sh (-35.07%)
Steven Cohen 153,273 sh (-70.11%)
» More
Q1 2014

UHS Guru Trades in Q1 2014

Jim Simons 81,800 sh (New)
Joel Greenblatt 426,527 sh (+189.38%)
Paul Tudor Jones 16,869 sh (+129.39%)
Manning & Napier Advisors, Inc 322,320 sh (+58.58%)
Vanguard Health Care Fund 4,259,600 sh (+9.96%)
Private Capital 406,006 sh (+1.02%)
Ron Baron 405,540 sh (unchged)
Steven Cohen Sold Out
Jeremy Grantham Sold Out
Chris Davis 145,600 sh (-1.36%)
Mariko Gordon 44,452 sh (-2.66%)
Andreas Halvorsen 2,759,799 sh (-8.31%)
Westport Asset Management 856,558 sh (-9.58%)
Ray Dalio 5,400 sh (-56.8%)
» More
Q2 2014

UHS Guru Trades in Q2 2014

Caxton Associates 20,000 sh (New)
Louis Moore Bacon 50,000 sh (New)
Larry Robbins 124,896 sh (New)
Mariko Gordon 48,682 sh (+9.52%)
Ron Baron 435,670 sh (+7.43%)
Vanguard Health Care Fund 4,484,600 sh (+5.28%)
Steven Cohen 50,000 sh (unchged)
Chris Davis 145,600 sh (unchged)
Jim Simons Sold Out
Ray Dalio Sold Out
Private Capital 393,226 sh (-3.15%)
Westport Asset Management 820,858 sh (-4.17%)
Joel Greenblatt 333,786 sh (-21.74%)
Andreas Halvorsen 1,277,443 sh (-53.71%)
Manning & Napier Advisors, Inc 125,500 sh (-61.06%)
Paul Tudor Jones 4,400 sh (-73.92%)
» More
» Details

Insider Trades

Latest Guru Trades with UHS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2014-06-30 Reduce -21.74%0.12%$74.61 - $98.75 $ 11331%333786
Ray Dalio 2014-06-30 Sold Out $74.61 - $98.75 $ 11331%0
Joel Greenblatt 2014-03-31 Add 189.38%0.35%$74.35 - $85.8 $ 11340%426527
Ray Dalio 2014-03-31 Reduce -56.8%$74.35 - $85.8 $ 11340%5400
Ray Dalio 2013-12-31 Add 27.55%$75.88 - $83.12 $ 11341%12500
Joel Greenblatt 2013-09-30 Add 86.9%0.14%$63.83 - $74.29 $ 11362%123498
Ron Baron 2013-09-30 Add 34.51%0.04%$63.83 - $74.29 $ 11362%405540
Ray Dalio 2013-09-30 New Buy0.01%$63.83 - $74.29 $ 11362%9800
Mariko Gordon 2013-06-30 New Buy0.13%$60.12 - $71.2 $ 11371%41100
Jean-Marie Eveillard 2013-06-30 Sold Out 0.13%$60.12 - $71.2 $ 11371%0
Ron Baron 2013-06-30 Add 50.15%0.04%$60.12 - $71.2 $ 11371%301490
Joel Greenblatt 2013-06-30 Add 21.02%0.03%$60.12 - $71.2 $ 11371%66076
Ron Baron 2013-03-31 New Buy0.07%$48.35 - $64.38 $ 11398%200790
Jean-Marie Eveillard 2013-03-31 Reduce -31.67%0.05%$48.35 - $64.38 $ 11398%630691
Jean-Marie Eveillard 2012-09-30 New Buy0.15%$38.17 - $45.75 $ 113174%898114
Joel Greenblatt 2012-09-30 Add 40.83%0.05%$38.17 - $45.75 $ 113174%57186
Joel Greenblatt 2012-03-31 New Buy0.15%$36.82 - $44.78 $ 113190%40315
George Soros 2011-09-30 Sold Out 0.0036%$34.03 - $54.64 $ 113163%0
George Soros 2011-06-30 Reduce -65.03%0.01%$46.13 - $56.41 $ 113118%5000
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Guru Investment Theses on Universal Health Services Inc

Mario Gabelli Comments on UnitedHealth Group Inc - Jul 30, 2014

UnitedHealth Group Inc. (UHS) (0.2%) (UNH - $81.75 - NYSE) is the largest and most diverse health care company in the United States. United insures over forty million people around the world, but also provides over $40 billion worth of technology, pharmacy benefits management, and other care services through its Optum division. The company has successfully navigated the changes required by the Affordable Care Act and is winning new business in state Medicaid programs and in a limited number of state exchanges. UnitedHealth is also finding new growth internationally, especially in Brazil where the company now serves over four million people.

From Mario Gabelli (Trades, Portfolio)’s The Gabelli Asset Fund Second Quarter 2014 Shareholder Commentary.

Check out Mario Gabelli latest stock trades

Westport Select Cap Fund Comments on Universal Health Services Inc - Jul 28, 2014

The second largest contributor to first half performance was Universal Health Services, Inc. (UHS), Class B shares, the fund’s largest position. The operator of acute care and mental health hospitals gained nearly 18% and contributed 182 basis points. First quarter earnings exceeded estimates, reflecting the early positive impact of the Affordable Care Act (also known as “Obamacare.”)

From Westport Asset Management (Trades, Portfolio)’s Westport Select Cap Fund Second Quarter 2014 Commentary.

Check out Westport Asset Management latest stock trades

Westport Fund Comments on Universal Health Services Inc - Jul 28, 2014

Health care holdings were the second largest industry sector contribution to the Fund’s performance at 128 basis points, similar to the 138 basis points contribution of the health care sector to the Russell Midcap® Index. The best performer among the portfolio holdings in health care was Universal Health Services, Inc., Class B shares (UHS) which contributed 64 basis points to performance with an 18% return in the first half.

From Westport Asset Management (Trades, Portfolio)’s Westport Fund Second Quarter 2014 Commentary.

Check out Westport Asset Management latest stock trades

Baron Funds Comments on Universal Health Services Inc. - Nov 06, 2013

The Fund continues to search for companies that will be long-term beneficiaries of the major changes impacting the U.S. healthcare system. During the past three quarters, we established a position in Universal Health Services, Inc. (UHS), a private hospital company with a unique business model. UHS is a leading operator of acute care hospitals, and it is also the nation's largest operator of behavioral health hospitals, which treat patients with mental illnesses. We believe UHS has an attractive business mix, with approximately half its revenues coming from acute care (i.e., traditional hospitals) and half coming from high-margin, low capital intensive behavioral health hospitals. We believe that both segments should benefit from expanded insurance coverage under healthcare reform.

UHS is the largest provider of behavioral health services in the U.S., with market share of approximately 35% – 40% of freestanding behavioral hospitals. We believe this is an attractive sector within the private hospital industry, which is currently undervalued by the market. This sector has benefitted from lack of additional capacity, the relative absence of consolidated competitors, a favor able reimbursement regime, and modest bad debt expense. We believe that demand for behavioral health services is economically insensitive, as evidenced by UHS's achieving same store revenue growth of approximately 5% in this segment throughout the recession. And, we believe that healthcare reform should lead to an expanded pool of potential paying patients. Broader healthcare coverage is also likely to uncover more previously underdiagnosed and undertreated mentally ill patients. Furthermore, current capacity at UHS's behavioral health facilities is running about 1,000 basis points below its peak, and the margin on incremental patients is high.

In the acute care segment, we believe that UHS should also benefit from lower bad debt expense and higher utilization from expanded insurance coverage. UHS' geographically dispersed acute hospitals benefit from being market share leaders in some of the country's fastest growing markets where population growth is expected to be approximately 9%, twice the national level. In fact, 97% of the company's EBITDA comes from hospitals that are #1 or #2 in their markets; these dominant franchises make UHS a "must have" provider for managed care contracts and positions the company well for narrow networks under healthcare exchanges. Lastly, UHS has the lowest leverage among its for profit peers, leaving flexibility for acquisitions and accretive share repurchases.

From Ron Baron's Baron Funds third quarter 2013 report.


Check out Ron Baron latest stock trades

Westport Asset Management Comments on Universal Health Services Inc. - Aug 08, 2013

By far the biggest contributor to first half performance was the Westport Select Cap Fund's largest holding, Universal Health Services, Inc. (UHS), Class B shares. This operator of acute care and mental health hospitals gained over 38% and contributed 393 basis points to performance. Once again investors focused on the company as a prime beneficiary of the 2014 implementation of the Affordable Care Act, known by most commentators as "Obamacare."

From Westport Asset Management's second quarter 2013 letter.
Check out Westport Asset Management latest stock trades

Top Ranked Articles about Universal Health Services Inc

Westport Select Cap Fund Comments on Universal Health Services Inc
The second largest contributor to first half performance was Universal Health Services, Inc. (UHS), Class B shares, the fund’s largest position. The operator of acute care and mental health hospitals gained nearly 18% and contributed 182 basis points. First quarter earnings exceeded estimates, reflecting the early positive impact of the Affordable Care Act (also known as “Obamacare.”) Read more...
Westport Fund Comments on Universal Health Services Inc
Health care holdings were the second largest industry sector contribution to the Fund’s performance at 128 basis points, similar to the 138 basis points contribution of the health care sector to the Russell Midcap® Index. The best performer among the portfolio holdings in health care was Universal Health Services, Inc., Class B shares (UHS) which contributed 64 basis points to performance with an 18% return in the first half. Read more...
Baron Funds Comments on Universal Health Services Inc.
The Fund continues to search for companies that will be long-term beneficiaries of the major changes impacting the U.S. healthcare system. During the past three quarters, we established a position in Universal Health Services, Inc. (UHS), a private hospital company with a unique business model. UHS is a leading operator of acute care hospitals, and it is also the nation's largest operator of behavioral health hospitals, which treat patients with mental illnesses. We believe UHS has an attractive business mix, with approximately half its revenues coming from acute care (i.e., traditional hospitals) and half coming from high-margin, low capital intensive behavioral health hospitals. We believe that both segments should benefit from expanded insurance coverage under healthcare reform. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 21.40
UHS's P/E(ttm) is ranked higher than
86% of the 261 Companies
in the Global Medical Care industry.

( Industry Median: 44.00 vs. UHS: 21.40 )
UHS' s 10-Year P/E(ttm) Range
Min: 8.06   Max: 25.79
Current: 21.4

8.06
25.79
P/B 3.10
UHS's P/B is ranked higher than
60% of the 261 Companies
in the Global Medical Care industry.

( Industry Median: 2.96 vs. UHS: 3.10 )
UHS' s 10-Year P/B Range
Min: 1.01   Max: 3.13
Current: 3.1

1.01
3.13
P/S 1.50
UHS's P/S is ranked higher than
61% of the 261 Companies
in the Global Medical Care industry.

( Industry Median: 1.55 vs. UHS: 1.50 )
UHS' s 10-Year P/S Range
Min: 0.32   Max: 1.5
Current: 1.5

0.32
1.5
PFCF 20.30
UHS's PFCF is ranked higher than
71% of the 261 Companies
in the Global Medical Care industry.

( Industry Median: 34.00 vs. UHS: 20.30 )
UHS' s 10-Year PFCF Range
Min: 8.5   Max: 333.88
Current: 20.3

8.5
333.88
EV-to-EBIT 13.95
UHS's EV-to-EBIT is ranked higher than
88% of the 261 Companies
in the Global Medical Care industry.

( Industry Median: 26.73 vs. UHS: 13.95 )
UHS' s 10-Year EV-to-EBIT Range
Min: 6.6   Max: 16.7
Current: 13.95

6.6
16.7
PEG 1.10
UHS's PEG is ranked higher than
97% of the 261 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. UHS: 1.10 )
UHS' s 10-Year PEG Range
Min: 0.37   Max: 4.12
Current: 1.1

0.37
4.12
Shiller P/E 28.70
UHS's Shiller P/E is ranked higher than
81% of the 261 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. UHS: 28.70 )
UHS' s 10-Year Shiller P/E Range
Min: 8.32   Max: 28.7
Current: 28.7

8.32
28.7
Current Ratio 1.37
UHS's Current Ratio is ranked higher than
72% of the 170 Companies
in the Global Medical Care industry.

( Industry Median: 1.55 vs. UHS: 1.37 )
UHS' s 10-Year Current Ratio Range
Min: 0.95   Max: 1.98
Current: 1.37

0.95
1.98
Quick Ratio 1.28
UHS's Quick Ratio is ranked higher than
72% of the 170 Companies
in the Global Medical Care industry.

( Industry Median: 1.32 vs. UHS: 1.28 )
UHS' s 10-Year Quick Ratio Range
Min: 0.82   Max: 1.78
Current: 1.28

0.82
1.78

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.20
UHS's Dividend Yield is ranked lower than
96% of the 146 Companies
in the Global Medical Care industry.

( Industry Median: 1.51 vs. UHS: 0.20 )
UHS' s 10-Year Dividend Yield Range
Min: 0.14   Max: 0.99
Current: 0.2

0.14
0.99
Dividend Payout 0.04
UHS's Dividend Payout is ranked higher than
100% of the 261 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. UHS: 0.04 )
UHS' s 10-Year Dividend Payout Range
Min: 0.03   Max: 0.53
Current: 0.04

0.03
0.53
Yield on cost (5-Year) 0.28
UHS's Yield on cost (5-Year) is ranked lower than
97% of the 151 Companies
in the Global Medical Care industry.

( Industry Median: 1.91 vs. UHS: 0.28 )
UHS' s 10-Year Yield on cost (5-Year) Range
Min: 0.19   Max: 1.36
Current: 0.28

0.19
1.36
Share Buyback Rate -0.50
UHS's Share Buyback Rate is ranked higher than
81% of the 175 Companies
in the Global Medical Care industry.

( Industry Median: -1.40 vs. UHS: -0.50 )
UHS' s 10-Year Share Buyback Rate Range
Min: 6.8   Max: -1.6
Current: -0.5

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 24.40
UHS's Price/Tangible Book is ranked lower than
51% of the 261 Companies
in the Global Medical Care industry.

( Industry Median: 12.90 vs. UHS: 24.40 )
UHS' s 10-Year Price/Tangible Book Range
Min: 1.5   Max: 326.64
Current: 24.4

1.5
326.64
Price/DCF (Projected) 1.50
UHS's Price/DCF (Projected) is ranked higher than
79% of the 261 Companies
in the Global Medical Care industry.

( Industry Median: 53.00 vs. UHS: 1.50 )
UHS' s 10-Year Price/DCF (Projected) Range
Min: 0.77   Max: 33.96
Current: 1.5

0.77
33.96
Price/Median PS Value 2.00
UHS's Price/Median PS Value is ranked higher than
68% of the 261 Companies
in the Global Medical Care industry.

( Industry Median: 1.20 vs. UHS: 2.00 )
UHS' s 10-Year Price/Median PS Value Range
Min: 0.51   Max: 2.17
Current: 2

0.51
2.17
Price/Peter Lynch Fair Value 1.10
UHS's Price/Peter Lynch Fair Value is ranked higher than
95% of the 261 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. UHS: 1.10 )
UHS' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.43   Max: 3.56
Current: 1.1

0.43
3.56
Price/Graham Number 4.60
UHS's Price/Graham Number is ranked higher than
70% of the 261 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. UHS: 4.60 )
UHS' s 10-Year Price/Graham Number Range
Min: 0.96   Max: 11.79
Current: 4.6

0.96
11.79
Earnings Yield (Greenblatt) 7.20
UHS's Earnings Yield (Greenblatt) is ranked higher than
79% of the 235 Companies
in the Global Medical Care industry.

( Industry Median: 5.20 vs. UHS: 7.20 )
UHS' s 10-Year Earnings Yield (Greenblatt) Range
Min: 6   Max: 15.1
Current: 7.2

6
15.1
Forward Rate of Return (Yacktman) 20.90
UHS's Forward Rate of Return (Yacktman) is ranked higher than
88% of the 210 Companies
in the Global Medical Care industry.

( Industry Median: 11.21 vs. UHS: 20.90 )
UHS' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 9.7   Max: 28.1
Current: 20.9

9.7
28.1

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, FMS, DVA, FSNUY, BDUUF » details
Traded in other countries:UHID.USA, UHS.Germany
Universal Health Services, Inc., is a Delaware corporation organized in 1979. The Company through its subsidiaries is engaged in the business of owning and operating, acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers and radiation oncology centers. The Company owned and/or operated 23 acute care hospitals and 197 behavioral health centers located in 37 states, Washington, D.C., Puerto Rico and the U.S. Virgin Islands. Services provided by hospitals include general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services and behavioral health services. The Company provides capital resources as well as management services to facilities, including central purchasing, information services, finance and control systems, facilities planning, physician recruitment services, administrative personnel management, marketing and public relations. The Company's reportable operating segments consist of acute care hospital services and behavioral health care services. The 'Other' segment includes centralized services including information services, purchasing, reimbursement, accounting, taxation, legal, advertising, design and construction and patient accounting as well as the operating results for its other operating entities including outpatient surgery and radiation centers. All of the Company's acute care hospitals and its behavioral health centers are certified as providers of Medicare and Medicaid services by the appropriate governmental authorities. Medicare is a federal program that provides certain hospital and medical insurance benefits to persons aged 65 and over, some disabled persons and persons with end-stage renal disease. Medicaid is a joint federal-state funded health care benefit program that is administered by the states to provide benefits to qualifying individuals who are unable to afford care. Most state Medicaid payments are made under a PPS-like system, or under programs that negotiate payment levels with individual hospitals. The Company's hospitals also provide services to individuals covered by private health care insurance. Private insurance carriers typically make direct payments to hospitals or, in some cases, reimburse their policy holders, based upon the particular hospital's established charges and the particular coverage provided in the insurance policy. Its hospitals provide services to individuals that do not have any form of health care coverage. Such patients are evaluated, at the time of service or shortly thereafter, for their ability to pay based upon federal and state poverty guidelines, qualifications for Medicaid or other state assistance programs, as well as its local hospital's indigent and charity care policy. The Company faces competition for acquisition candidates mainly from other for-profit health care companies, as well as from not-for-profit
» More Articles for UHS

Headlines

Articles On GuruFocus.com
Time to Buy Tenet Healthcare? Aug 22 2014 
Mario Gabelli Comments on UnitedHealth Group Inc Jul 30 2014 
Westport Select Cap Fund Comments on Universal Health Services Inc Jul 28 2014 
Westport Asset Management’s Westport Select Cap Fund Second Quarter 2014 Commentary Jul 28 2014 
Westport Fund Comments on Universal Health Services Inc Jul 28 2014 
Westport Funds - Westport Select Cap Fund Fourth Quarter Commentary Mar 28 2014 
Baron Funds Comments on Universal Health Services Inc. Nov 06 2013 
Westport Asset Management Comments on Universal Health Services Inc. Aug 08 2013 
Westport Funds Selects 1 Stock in Q2 Aug 08 2013 
4 Top-Performing Healthcare Dividend Stocks with Single-Digit P/Es Jul 02 2013 

More From Our Partners
Top 4 NYSE Stocks In The Hospitals Industry With The Highest Revenue Aug 21 2014 - BENZINGA

More From Other Websites
UNIVERSAL HEALTH SERVICES INC Financials Aug 15 2014
UNIVERSAL HEALTH SERVICES INC Files SEC form 8-K, Entry into a Material Definitive Agreement,... Aug 12 2014
How Universal Health Services (UHS) Stock Stands Out in a Strong Industry Aug 12 2014
3 Stocks Dragging In The Health Services Industry Aug 08 2014
UNIVERSAL HEALTH SERVICES INC Files SEC form 10-Q, Quarterly Report Aug 08 2014
UNIVERSAL HEALTH SERVICES INC Files SEC form 8-K, Entry into a Material Definitive Agreement,... Aug 04 2014
Wall Street Transcript Interview with Todd J. Meredith, the Executive Vice President - Investments -... Aug 04 2014
Creating Value for Senior Housing REITs: Is Obamacare a Long Term Tailwind? A Wall Street Transcript... Aug 01 2014
Will Universal Health Services (UHS) Continue to Surge Higher? Jul 31 2014
Earnings Estimates Moving Higher for Universal Health Services (UHS): Time to Buy? Jul 31 2014
Universal Health Services, Inc. Announces Offering Of Senior Secured Notes Jul 29 2014
Universal Health Services, Inc. Announces Offering Of Senior Secured Notes Jul 29 2014
Hospital Stocks Rise As ObamaCare Boosts Earnings Jul 28 2014
[video] Under the radar: UHS, XHB & more Jul 28 2014
Will This Price Target Increase Help United Health Services (UHS) Stock Today? Jul 28 2014
Universal Health Services: A Better Buy Than Tenet Health Care and HCA Holdings? Jul 27 2014
3 Health Services Stocks On The Rise Jul 25 2014
Hospitals Rally On LifePoint's ObamaCare-Pumped Q2 Jul 25 2014
Universal Health Services Inc Earnings Call scheduled for 9:00 am ET today Jul 25 2014
UNIVERSAL HEALTH SERVICES INC Files SEC form 8-K, Results of Operations and Financial Condition,... Jul 25 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide